DANIEL CORBIN: Open Payments
NPI 1396253563 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,299 in 38 payments from 9 companies in 2025. Trend: 2023 $673 · 2024 $447 · 2025 $11,299
Speaker / faculty: $8,988Travel & lodging: $1,546Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 28 | $11,106 |
| Novo Nordisk Inc | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| ViiV Healthcare Company | 1 | $27 |
| Exact Sciences Corporation | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: Yeztugo, Descovy, APRETUDE, Cologuard Collection Kit, FARXIGA, Ozempic, Wegovy, Auvelity.
Industry payments across NC — which companies pay providers there.
